In the BioHarmony Drug Report Database

"Preview" Icon

Methazolamide

Neptazane (methazolamide) is a small molecule pharmaceutical. Methazolamide was first approved as Neptazane on 1982-01-01. It is used to treat angle-closure glaucoma and open-angle glaucoma in the USA. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 4, carbonic anhydrase 14, carbonic anhydrase 1, and carbonic anhydrase 12.

 

Trade Name

 

Neptazane
 

Common Name

 

methazolamide
 

ChEMBL ID

 

CHEMBL19
 

Indication

 

angle-closure glaucoma, open-angle glaucoma
 

Drug Class

 

Carbonic anhydrase inhibitors

Image (chem structure or protein)

Methazolamide structure rendering